I agree that this site is using cookies. You can find further informations here.
X
Lynn, Melvyn
45  results:
Search for persons X
?
1

Safety, pharmacokinetics and pharmacodynamics of four-hour ..:

Aikawa, Naoki ; Okubo, Yoshio ; Lynn, Melvyn...
Innate Immunity.  18 (2012)  6 - p. 793-803 , 2012
Link: https://doi.org/10.1177/..
 
?
2

Deactivation of the lipopolysaccharide antagonist eritoran ..:

Fleischer, Jacklyn G ; Rossignol, Dan ; Francis, Gordon A...
Innate Immunity.  18 (2011)  1 - p. 171-178 , 2011
Link: https://doi.org/10.1177/..
 
?
3

Continuous pharmacodynamic activity of eritoran tetrasodium..:

Rossignol, Daniel P. ; Wong, Nancy ; Noveck, Robert.
Innate Immunity.  14 (2008)  6 - p. 383-394 , 2008
Link: https://doi.org/10.1177/..
 
?
4

Influence of Plasma Cholesterol and Triglyceride Concentrat..:

Wasan, Kishor M. ; Risovic, Verica ; Sivak, Olena...
Pharmaceutical Research.  25 (2007)  1 - p. 176-182 , 2007
Link: https://doi.org/10.1007/..
 
?
5

Elevated Plasma Levels of Limulus Amoebocyte Lysate-Reactiv..:

Rossignol, Daniel ; Lynn, Melvyn ; Wittek, Alec...
The Journal of Infectious Diseases.  194 (2006)  9 - p. 1340-1341 , 2006
Link: https://www.jstor.org/st..
 
?
6

Elevated Plasma Levels of Limulus Amoebocyte Lysate–Reactiv..:

Rossignol, Daniel ; Lynn, Melvyn ; Wittek, Alec.
The Journal of Infectious Diseases.  194 (2006)  9 - p. 1340-1340 , 2006
Link: https://doi.org/10.1086/..
 
?
7

Blocking of Responses to Endotoxin by E5564 in Healthy Volu..:

Lynn, Melvyn ; Rossignol, Daniel P. ; Wheeler, Janice L....
The Journal of Infectious Diseases.  187 (2003)  4 - p. 631-639 , 2003
Link: https://www.jstor.org/st..
 
?
8

Blocking of Responses to Endotoxin by E5564 in Healthy Volu..:

Lynn, Melvyn ; Rossignol, Daniel P. ; Wheeler, Janice L....
The Journal of Infectious Diseases.  187 (2003)  4 - p. 631-639 , 2003
Link: https://doi.org/10.1086/..
 
?
9

Safety, Pharmacokinetics, and Pharmacodynamics of E5564, a ..:

Wong, Y. Nancy ; Rossignol, Daniel ; Rose, Jeffrey R....
The Journal of Clinical Pharmacology.  43 (2003)  7 - p. 735-742 , 2003
Link: https://doi.org/10.1177/..
 
?
10

Safety, Pharmacokinetics, and Pharmacodynamics of E5564, a ..:

Wong, Y. N. ; Rossignol, Daniel ; Rose, Jeffrey R....
Journal of Clinical Pharmacology.  43 (2003)  7 - p. 735-742 , 2003
Link: https://doi.org/10.1177/..
 
?
11

A lipid A analog, E5531, blocks the endotoxin response in h..:

Bunnell, Eugene ; Lynn, Melvyn ; Habet, Kalim...
Critical Care Medicine.  28 (2000)  8 - p. 2713-2720 , 2000
Link: https://doi.org/10.1097/..
 
?
12

EFFECT OF E5531 ON SYSTEMIC RESPONSES TO ENDOTOXIN IN HEALT..:

Bunnell, Eugene ; Lynn, Melvyn ; Parrillo, Joseph E....
Critical Care Medicine.  23 (1995)  Supplement - p. A147 , 1995
Link: https://doi.org/10.1097/..
 
?
13

E5531, AN ENDOTOXIN ANTAGONIST, BLOCKS THE HYPERDYNAMIC AND..:

Bunnell, Eugene ; Neumann, Alex ; Lynn, Melvyn...
Critical Care Medicine.  23 (1995)  Supplement - p. A151 , 1995
Link: https://doi.org/10.1097/..
 
?
14

The Role of Slime Polysaccharide in Infections with Pseudom..:

Lynn, Melvyn ; Young, Lowell S.
The Journal of Infectious Diseases.  143 (1981)  5 - p. 755-756 , 1981
Link: https://www.jstor.org/st..
 
?
15

Safety, Pharmacokinetics, Pharmacodynamics, and Plasma Lipo..:

Rossignol, Daniel P ; Wasan, Kishor M ; Choo, Eugene...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC514793.  , 2004
Link: http://www.ncbi.nlm.nih...
 
1-15